My Lords, given that I took the order through Parliament many years ago, I can confirm that the whole intention was that the NHS had 90 days to prepare for funding a medicine that had been designated by NICE as both clinically and cost effective. The problem is that, subsequently, in particular over the past few years, clinical commissioning groups have done everything they can to avoid this responsibility. Alongside that, the purity of the 90-day rule is being eaten into, and that is at the heart of the concern of this amendment.
Health Service Medical Supplies (Costs) Bill
Proceeding contribution from
Lord Hunt of Kings Heath
(Labour)
in the House of Lords on Tuesday, 7 February 2017.
It occurred during Debate on bills on Health Service Medical Supplies (Costs) Bill.
About this proceeding contribution
Reference
778 c1639 Session
2016-17Chamber / Committee
House of Lords chamberSubjects
Librarians' tools
Timestamp
2017-02-10 18:30:31 +0000
URI
http://hansard.intranet.data.parliament.uk/Lords/2017-02-07/17020793000052
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2017-02-07/17020793000052
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2017-02-07/17020793000052